Recent studies of interferon (IFN) have revealed evidence that IFNs (alpha-IFN, beta-IFN, and gamma-IFN) have cell proliferation regulatory, immunoregulatory, antitumor, and antiviral functions (1, 2, 15). These activities of IFN are associated with the system of defense against viral infection. Furthermore, each type of IFN has the capacity to induce oligo-2',5'-adenylate synthetase, which plays an important role in the antiviral function in cultured cells and peripheral blood mononuclear leukocytes (PBMLs) (8) . Hence, measurement of the activity of this enzyme indicates that IFNs are present in the circulation and, furthermore, that PBMLs have the capacity to respond to IFN. Oligo-2',5'-adenylate synthetase was assayed in viral diseases and IFN therapy, and it was clear that the activity of this enzyme increased in patients with acute viral infections (9, 10) . It has been reported that IFN was detectable in the circulation of patients with several idiopathic inflammatory diseases, such as systemic lupus erythematosus (SLE) (4, 6, 14) , sarcoidosis (Y. Niizu, personal communication), Vogt-KoyanagiHarada (VKH) disease (T. Minagawa, manuscript in preparation), and Behget's disease (5; S. Arimori, personal communication). The role of IFN in the pathogenesis of these diseases is unknown.
In this paper, we examined oligo-2',5'-adenylate synthetase activity in 38 samples (22 of them were in the active stage, and the others were in the inactive stage) of PBMLs from patients with SLE, 20 samples from sarcoidosis patients, 10 samples from VKH disease patients, and 28 samples from Behget's disease patients. These patients were diagnosed in the Uveitis Survey Clinic and Second Department of Internal Medicine Clinic of Hokkaido University Hospital. The diagnostic criteria for inclusion in this study were those proposed by the Japanese Research Committee on Behqet's disease (7) and by the American Rheumatism Association (13) . The diagnosis of VKH disease was made according to the definition of Sugiura (12) . Twenty patients with Behqet's disease were males, and eight were females.
Twenty of them belonged to the complete type, and eight belonged to the incomplete type. Twenty-seven patients were in the convalescent stage. Eighteen samples of PBMLs from healthy donors were used as controls.
The IFN assay was performed by the semimicro, dyebinding method (3, 5) . Human amnion cells (FiL cells, 4 x 104/0.1 ml) were inoculated into each well of the microplates (Nunc, Denmark). After cultivation of FiL cells for 24 h at 37°C in a CO2 incubator, the culture fluid in the microplates was discarded, and then 0.1 ml of serially twofold-diluted serum samples was inoculated into each well and further incubated for 24 h. After that, the microplates were washed with serum-free RPMI 1640 medium, and the cells in each well were challenged with 0.1 ml of vesicular stomatitis virus (Indiana strain). When the cytopathic effects induced by the virus were obvious, the cells were washed with a 0.85% NaCl solution, stained with Gentiana violet solution, washed with water, and dried at room temperature. The dye binding to the cells was dissolved with Methylserosolve, and the optical density was measured at a wavelength of 550 nm.
Peripheral blood of patients and healthy donors was obtained by venipuncture. PBMLs were obtained from heparinized blood by Ficoll-Hypaque sedimentation by methods described previously (3) . PBMLs (3 x 4.94 ± 0.56). Mann-Whitney's U test showed that the difference is highly significant in SLE (P < 0.01), VKH disease (P < 0.01), and sarcoidosis (P < 0.01); however, in Behqet's disease, the difference is not significant (P > 0.05). Patients with Behqet's disease showed higher levels of enzyme activity than the controls. Specifically, the number of patients with enzyme activity greater than 9.70 nmoI/mgh (mean + 2 standard deviations of the controls) was significantly greater in the patients than in the controls (P < 0.025). Most of the patients who had IFN activity in their circulation showed high enzyme activity in their PBMLs; however, in some patients, high enzyme activity was also detectable even though there was no IFN activity (Table 1) . It was reported that the oligo-2',5'-adenylate synthetase activity in PBMLs was also increased in the patients with Behqet's disease (11) . The Welch t test of the results reported by them indicated that the difference was significant (P < 0.05) in Behqet's disease.
In this paper, although the patients with Behqet's disease showed higher levels of the enzyme activity than the controls, the difference was not significant. 
